CD4+Foxp3+CD25+ Tregs are exclusively enriched in the TME through their recruitment by cytokines/chemokines and certain growth factors, namely vascular endothelial growth factor and transforming growth factor-β, exerting an anti-tumour immune response and tumour evasion [146,147]. This evidence concerns the gene FOXP3 and neoplasm.